ICARES Medicus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018
March 17, 2019 at 04:33 pm EDT
Share
ICARES Medicus, Inc. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 329.284 million compared to TWD 266.050 million a year ago. Operating income was TWD 86.186 million compared to TWD 63.540 million a year ago. Net income was TWD 70.453 million compared to TWD 31.246 million a year ago. Basic earnings per share was TWD 2.23 compared to TWD 1.03 a year ago. Diluted earnings per share was TWD 2.21 compared to TWD 1.03 a year ago.
Icares Medicus Inc is a Taiwan-based company mainly engaged in the authorization of high-end medical material surface treatment technology. The Company is also involved in the sale of surface treatment formulations and provision of customer surface treatment processing services, as well as the research and development, manufacture and sale of artificial lens and its implantation system. The Company's product revenue is mainly divided into three categories. The royalty income comes from the authorization of implantation/invasive high-end medical material surface treatment technology. The technical service income mainly includes implantation/invasive high-end medical surface treatment services, provision of medical coatings and foundry of artificial lens implantation systems. The sales of medical materials mainly include the sales of medical materials surface inspection equipment and other products. The Company distributes its products in domestic and overseas markets.
ICARES MEDICUS, INC. 
